Start for free
Start for free
IC

InVivium Capital

North America, Illinois, United States, Chicago

Description

InVivium Capital is a venture capital firm that focusses on investments in healthcare and life sciences.

Investor Profile

InVivium Capital has made 3 investments, with 1 in the past 12 months and 33% as lead.

Stage Focus

  • Series C (67%)
  • Series A (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Artificial Intelligence (Ai)
  • Biopharma
  • Neuroscience
  • Precision Medicine
  • Advanced Materials
  • Developer Platform
  • Health Care
  • Robotics
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does InVivium Capital frequently co-invest with?

Alexandria Venture Investments
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 1
Alkeon Capital
Alkeon Capital
North America, New York, United States, New York
Co-Investments: 1
What If Ventures
What If Ventures
North America, Texas, United States, Frisco
Co-Investments: 1
Franklin Templeton
Franklin Templeton
North America, California, United States, San Mateo
Co-Investments: 1
AW
Alpha Wave Ventures
North America, Florida, United States, Miami
Co-Investments: 1
Point72 Ventures
Point72 Ventures
North America, New York, United States, New York
Co-Investments: 1
Arboretum Ventures
Arboretum Ventures
North America, Michigan, United States, Ann Arbor
Co-Investments: 1
Windham Venture Partners
Windham Venture Partners
North America, New York, United States, New York
Co-Investments: 1
LC
Lightswitch Capital
North America, New York, United States, New York
Co-Investments: 2
Eli Lilly
Eli Lilly
North America, Indiana, United States, Indianapolis
Co-Investments: 1

What are some of recent deals done by InVivium Capital?

Hinge Bio

Burlingame, California, United States

Hinge Bio specializes in leveraging its proprietary Flex-Hinge antibody platform to develop bispecific and multispecific antibodies.

BiotechnologyLife ScienceMedical
Series AJan 15, 2025
Amount Raised: $30,000,000
Alto Neuroscience

Los Altos, California, United States

Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.

Artificial Intelligence (AI)BiopharmaBiotechnologyNeurosciencePrecision Medicine
Series CNov 21, 2023
Amount Raised: $45,000,000
Virtual Incision

Lincoln, Nebraska, United States

Virtual Incision develops a miniaturized surgical robotic support device with a focus on colon resection.

Advanced MaterialsDeveloper PlatformHealth CareRobotics
Series CSep 19, 2023
Amount Raised: $30,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator